BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 20498880)

  • 1. Gene expression analysis on a photodiode array-based bioluminescence analyzer by using sensitivity-improved SRPP.
    Song Q; Jing H; Wu H; Zhou G; Kajiyama T; Kambara H
    Analyst; 2010 Jun; 135(6):1315-9. PubMed ID: 20498880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dye-free gene expression detection by sequence-tagged reverse-transcription polymerase chain reaction coupled with pyrosequencing.
    Zhang X; Wu H; Chen Z; Zhou G; Kajiyama T; Kambara H
    Anal Chem; 2009 Jan; 81(1):273-81. PubMed ID: 19049364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico identification of breast cancer genes by combined multiple high throughput analyses.
    Shen D; He J; Chang HR
    Int J Mol Med; 2005 Feb; 15(2):205-12. PubMed ID: 15647832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
    Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
    Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
    Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
    Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The melanoma antigen gene as a surveillance marker for the detection of circulating tumor cells in patients with breast carcinoma.
    Kwon S; Kang SH; Ro J; Jeon CH; Park JW; Lee ES
    Cancer; 2005 Jul; 104(2):251-6. PubMed ID: 15937912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous detection of multiple mRNA markers CK19, CEA, c-Met, Her2/neu and hMAM with membrane array, an innovative technique with a great potential for breast cancer diagnosis.
    Chen CC; Hou MF; Wang JY; Chang TW; Lai DY; Chen YF; Hung SY; Lin SR
    Cancer Lett; 2006 Aug; 240(2):279-88. PubMed ID: 16289546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of the real-time RT-PCR method for investigation of small stable RNA expression level in human epidermoid carcinoma cells A431].
    Nikitina TV; Nazarova NIu; Tishchenko LI; Tuohimaa P; Sedova VM
    Tsitologiia; 2003; 45(4):392-402. PubMed ID: 14520871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scanning copy number and gene expression on the 18q21-qter chromosomal region by the systematic multiplex PCR and reverse transcription-PCR methods.
    Yamamoto F; Yamamoto M
    Electrophoresis; 2007 Jun; 28(12):1882-95. PubMed ID: 17523142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal residual disease detection in breast cancer: improved sensitivity using cytokeratin 19 and epidermal growth factor receptor RT-PCR.
    Fellowes VS; Husebekk A; Gress RE; Vance BA
    Int J Oncol; 2004 Apr; 24(4):861-7. PubMed ID: 15010823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
    Yang DC; Wang F; Elliott RL; Head JF
    Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alternative method to amplify RNA without loss of signal conservation for expression analysis with a proteinase DNA microarray in the ArrayTube format.
    Schüler S; Wenz I; Wiederanders B; Slickers P; Ehricht R
    BMC Genomics; 2006 Jun; 7():144. PubMed ID: 16768788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors.
    de Kok JB; Verhaegh GW; Roelofs RW; Hessels D; Kiemeney LA; Aalders TW; Swinkels DW; Schalken JA
    Cancer Res; 2002 May; 62(9):2695-8. PubMed ID: 11980670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of oestrogen receptor expression in breast cancer by quantification of mRNA.
    Potemski P; Pluciennik E; Bednarek AK; Kusinska R; Kubiak R; Kordek R
    Histopathology; 2007 Dec; 51(6):829-36. PubMed ID: 18042072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen.
    Ghadersohi A; Sood AK
    Clin Cancer Res; 2001 Sep; 7(9):2731-8. PubMed ID: 11555586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay.
    Bièche I; Laurendeau I; Tozlu S; Olivi M; Vidaud D; Lidereau R; Vidaud M
    Cancer Res; 1999 Jun; 59(12):2759-65. PubMed ID: 10383126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of Her-2/neu (ERBB2) gene expression using reverse transcriptase polymerase chain reaction.
    Sarkar FH; Visscher DW; Crissman JD
    Diagn Mol Pathol; 1993 Sep; 2(3):210-8. PubMed ID: 7506983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness.
    Pedraza V; Gomez-Capilla JA; Escaramis G; Gomez C; Torné P; Rivera JM; Gil A; Araque P; Olea N; Estivill X; Fárez-Vidal ME
    Cancer; 2010 Jan; 116(2):486-96. PubMed ID: 20029976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.